Overexpression of matrix metalloproteinases (MMPs) is associated with cancer metastasis. We assessed mRNA expression of MMPs in six human colorectal cancer cell lines and found a considerable level of MMP-7 expression in HT-29 cells. Next, we searched for natural and synthetic compounds that cause a reduction in the production of proMMP-7 protein, and found that nobiletin (NOB), quercetin, valeryl salicylate, and sulindac sulfone demonstrated marked inhibition. Importantly, NOB attenuated proMMP-7 protein and its mRNA expression both concentration-and time-dependently via a reduction of activator protein-1 (AP-1) DNA binding activity, suggesting it as a promising agent for suppression of cancer cell invasion and metastasis through MMP-7 gene repression.
Matrix metalloproteinases (MMPs) are a large family of enzymes that contribute to the maintenance of extracellular matrix components, such as collagens, gelatin, and fibronectin. MMPs play many roles in normal and pathological states, including embryogenesis, wound healing, arthritis, and inflammation. Their role as accelerators of cancer invasion and metastasis has also received attention, since tumor metastasis is correlated with type IV collagenolytic activity, which is known to be identical with the activities of MMP-2 and MMP-9.
1)
MMP-7 (matrilysin) is secreted in a 28 kDa latent form (proMMP-7) by many kinds of cancer cells, though not from stromal cells, which are thought to be the main source of MMPs during invasion and metastasis, 2, 3) after which the 19 kDa active form of MMP-7 is generated by proteases such as trypsine. 4) Further, MMP-7 expression has been detected in various neoplastic tissues, including colorectal, 5) gastric, 6) breast, 7) pancreatic, 8) and esophageal 9) cancer tissues, with the level of expression in colorectal cancers known to be significantly correlated with clinicopathological characteristics, while a reverse association with 5-year patient survival rate has been shown. 10) Of interest, Heslin et al. found that the level of MMP-7 expression in colorectal adenoma was about 50-fold greater than in normal mucosa, 5) and Wilson and co-workers reported that intestinal tumor numbers and size in MMP-7 deficient Min/+ mice decreased by 58% and 20% respectively as compared with those in MMP-7
þ=þ Min/+ mice. 11) These findings suggest that the production of MMP-7 in the early-stage of carcinogenesis might have a progressive effect on the development of neoplastic tissues. Although the molecular mechanisms underlying MMP-7 gene expression remain to be fully elucidated, Brabletz et al. 12) and Crawford et al. 13) independently reported that -catenin is involved in the regulation of MMP-7 gene transcription, and that its transactivation is necessary for interaction with TCF-4, a member of the T cell factor (TCF)/lymphoid enhancer binding factor family. Moreover, thecatenin/TCF complex is known to cooperate with AP-1 for maximum expression. 14) While there are a large number of reports regarding MMP-9 suppressants, including catechins, 15) curcumin, 16) 1,25-dihydroxyvitamin D 3 , 17) peroxisome proliferator-activated receptor (PPAR) activators, 18) inhibitors of cyclooxygenase (COX) and phospholipase A 2 , 19) and nobiletin (NOB), [20] [21] [22] [23] those for MMP-7 are limited (e.g., retinoic acid, 24) butyrate, 25) and PPAR agonist troglitazone 26) ). In the present study, we investigated the expression of MMPs in human colorectal cancer cell lines and found a high level of MMP-7 mRNA in HT-29 cells. Next, we identified 4 functionally novel and promising proMMP-7 production inhibitors, one of which was NOB, and describe the pronounced effect of NOB on MMP-7 expression as well as the underlying molecular events. Cell cultures. Six human colorectal cancer cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA) and maintained in DMEM (Caco-2 and HT-29), RPMI1640 (Colo205 and Colo320DM), or EMEM with non-essential amino acids (LS174T and LS180) supplemented with 10% fetal bovine serum, 300 mg/ml of L-glutamine, 100 U/ml of penicillin, and 100 mg/ml of streptomycin, at 37 C in a humidified 5% CO 2 atmosphere. After 24 h of preincubation, cells (2 Â 10 5 cells/ml) in serum-free medium were used for the experiments. The compounds showed no cytotoxicity in any of the experiments at the tested concentrations (data not shown).
ELISA. Following pre-incubation, HT-29 cells (0:7 Â 10 5 cells/0.35 ml in a 24-well plate) were treated with natural and synthetic compounds (dissolved in a final concentration of 0.5% DMSO, v/v) for 24 h, after which the concentration of proMMP-7 protein in the medium was measured using the MMP-7 Human Biotrak ELISA System according to the manufacturer's instructions.
Western blotting. Following treatment with NOB (final concentration in DMSO, 0.05%, v/v), HT-29 cells (3:4 Â 10 5 cells/1.7 ml in a 6-well plate) were washed with phosphate buffer saline twice and lysed in lysis buffer [10 mM Tris, pH 7.4, 1% sodium dodecyl sulfate (SDS), 1 mM sodium vanadate (V)], and the lysates were boiled for 10 min. The media was then collected and centrifuged at 3;200 Â g for 5 min, and the resulting supernatant (750 ml) was incubated with 60% trichloroacetic acid (final, 3.75% v/v) at 4 C overnight. After centrifugation at 9;000 Â g for 10 min, the pellets were washed with 500 ml of ice-cold diethyl ether. Following centrifugation at 9;000 Â g for 10 min, the pellets were dried in a vacuum and then resuspended in 40 ml of sample buffer (0.125 M Tris, pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol). Samples (10 mg of lysate and 10 ml of supernatant protein) were separated on 10% polyacrylamide gels and transferred to Immobilon-P membranes (Millipore, Billerica, MA). After blocking with Block Ace (Snow Brand Milk Products, Tokyo, Japan) for 1 h, the membranes were incubated with mouse anti-MMP-7 antibody (1:1000) or goat anti--actin antibody (1:1000), and then with horseradish peroxidase-conjugated anti-mouse IgG (1:1000) or anti-goat IgG (1:1000). The blots were developed using ECL Western blotting detection reagents. Band intensities were analyzed using an NIHimage. Relative levels of MMP-7 were corrected withactin as the internal standard.
Reverse transcription-polymerase chain reaction (RT-PCR) for expression profiling of MMPs and MMP-7 expression analyses. Total RNA (1 Â 10 6 cells/5 ml in a 60-mm dish) was extracted using a QIAshredderÔ, RNase-Free DNase Set, and RNeasy Ò Mini Kit (Qiagen, Hilden, Germany), as indicated in the instruction manuals. Then 1 mg of RNA was reverse-transcribed to cDNA using an RNA PCR Kit (AMV) Ver. 2.1 (TaKaRa Bio, Shiga, Japan) with an Oligo-dT adaptor primer. The profiling of MMP mRNA (MMP-1, -2, -3, -7 and -9) expression was performed using an MPCR Kit for Human MMP Genes Set-3 (Maxim Biotech, South San Francisco, CA) according to the manufacturer's recommendations. Each band was amplified on a thermal cycler PTC-100 (MJ Research, Watertown, MA) with the following PCR conditions: 2 cycles at 96 C for 1 min and 59 C for 4 min, then 35 cycles at 94 C for 1 min and 59 C for 2 min. cDNA from MMP-7 or glyceraldehydes-3-phosphate dehydrogenase (GAPDH) in HT-29 cells was amplified using each primer in Platinum Ò PCR SuperMix. GAPDH was used as the internal standard. The primers for MMP-7 were 5 0 -TCTTTGGCCTACCTATAACTGG-3 0 and 5 0 -CTA-GACTGCTACCATCCGTC-3 0 (Proligo, Kyoto, Japan), which yielded an expected band size of 420 bp, while those for GAPDH were 5 0 -GTGAAGGTCGGAGT-CAACG-3 0 and 5 0 -GGTGAAGACGCCAGTGGACTC-3 0 (Proligo), which yielded an expected band size of 300 bp.
28) The primers were used at final concentrations of 0.15 mM and 0.05 mM respectively. PCR was performed with the following conditions: 28 cycles at 94 C for 30 sec, 55 C for 30 sec, and 72 C for 30 sec. 28) In each experiment, the PCR products were electrophoresed on 3% agarose gels and stained with 0.01% SYBR Ò Gold (Molecular probes, Eugene, OR).
Nuclear extraction and electrophoresis mobility shift assay (EMSA). HT-29 cells (1 Â 10 6 cells/5 ml in a 60-mm dish Â 4) were fractionated using a Nuclear/ Cytosol Fractionation Kit Ò (BioVision, Mountain View, CA), according to the recommendations of the supplier. EMSA for AP-1 was performed using EMSA ''Gel-Shift'' Kits (Panomics, Redwood, CA), with some modifications. Briefly, the nuclear extracts (100 mg) were reacted with a biotinylated-probe (hot probe, CGCTTGATGACTCAGCCGGAA + TTCCG-GCTGAGTCATCAAGCG, Bex, Tokyo, Japan) in EMSA buffer [2% glycerol, 1 mM MgCl 2 , 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl, 10 mM Tris-HCl (pH 7.5)] containing 1 mg of poly(dI-dC) . poly(dI-dC).
An unlabeled-probe (cold probe) was added at an amount 500-fold greater than the hot probe. Reaction mixtures were loaded onto 6% polyacrylamide gels and electrophoresed at 4 C at 120 V. The protein-oligonucleotide complex was then transferred onto a Biodyne B membrane (Pall, Ann Arbor, MI) for 30 min at 300 mA, and blocking and detection were performed using the reagents in the kit.
Results

Profiling of expression of MMPs in human colorectal cancer cell lines
We initially examined the expression of mRNA from MMPs (MMP-1, -2, -3, -7 and -9) in six human colorectal cancer cell lines using a multiplex RT-PCR method (Fig. 1) . MMP-1 mRNA was expressed in each of the cancer cell lines, except for LS180, and a similar profile was observed for MMP-2, whereas MMP-3 mRNA was not detectable in any of the cell lines examined. On the other hand, MMP-9 mRNA was highly expressed in Caco-2 and slightly in LS174T cells. Of importance, the expression level of MMP-7 mRNA in HT-29 cells was striking when compared with the other MMPs in the other cell lines. Thus, HT-29 cells, which carry mutant tumor suppressor genes (p53 29) and APC
30)
) and wildtype K-ras gene, 31) and showed invasiveness into matrigel-coated chamber inserts 32) and tumorigenicity in nude mice, 33) were used to examine the suppression effects on pro-MMP-7 production, as shown below.
Screening of natural and synthetic chemicals for suppression of proMMP-7 protein production
While treatment of the cells with indomethacin (a COX inhibitor) for 24 h slightly increased the production of proMMP-7 protein, SC-560 (a COX-1 inhibitor), 3(2)-t-butyl-4-hydroxyanisol (a synthetic antioxidant), and curcumin (the yellow pigment in turmeric) decreased it by 18.9%, 29.0% and 34.0%, respectively (Fig. 2) . L(þ)-ascorbic acid (vitamin C) and 4 0 -bromoflavone (a quinone reductase inducer) 34) each reduced it by 51.9%. Of note, proMMP-7 protein production was abolished by treatment with NOB, quercetin (an antioxidative flavonoid), valeryl salicylate (a COX-1 inhibitor), and sulindac sulfone [an inhibitor of guanosine 3 0 ,5 0 -cyclic monophosphate phosphodiesterase (cGMP PDE)]. 35) Since NOB has been shown to be a promising chemopreventive agent, 27, 36) we focused on the effect of this compound on MMP-7 production and underlying molecular mechanisms. HT-29 cells were treated with each compound for 24 h, after which proMMP-7 released into the media was evaluated using ELISA. 4
0 -bromoflavone and curcumin were each tested at a concentration of 20 mM, and the others at 100 mM. ND, not detectable.
Dose-dependent inhibition of MMP-7 expression
We incubated HT-29 cells with various concentrations (0-100 mM) of NOB for 24 h. Both intracellular and media proteins were analyzed using Western blotting, since proMMP-7 protein is secreted extracellularly. As shown in Fig. 3A , NOB at a concentration range of 25-100 mM reduced media proMMP-7 levels by 35% to 47%, and markedly diminished intracellular protein production by 85% (at 50 mM, p < 0:05) and 70% (at 100 mM, p < 0:05), as compared with non-treated cells. Further, NOB (50 and 100 mM) abolished MMP-7 mRNA expression, as detected by RT-PCR (Fig. 3B) .
Time-dependent inhibition of MMP-7 expression
Although not detectable until 6 h, proMMP-7 protein from vehicle-treated cells accumulated in the medium from 12 to 24 h, and NOB showed a marked inhibition of 32% to 61% (p < 0:05 at 24 h) (Fig. 4A) . Further, the constitutive production of intracellular proMMP-7 protein time-dependently declined in cells exposed to 50 mM of NOB at 6, 12, 18, and 24 h by 25%, 69%, 83% (p < 0:05), and 91% (p < 0:01) respectively (Fig. 4B) . In parallel, we observed that MMP-7 mRNA levels were remarkably reduced, by 9% to 28%, from 12 to 24 h after treatment with 50 mM of NOB (Fig. 4C) .
Inhibition of AP-1binding activity AP-1 is a homo-or heterodimeric protein composed of members of the c-jun and c-fos families, and is known to be an important transcription factor for MMP-7 gene expression. 14) We examined whether NOB affects the DNA binding activity of AP-1 by EMSA. Figure 5 shows that the binding activity of AP-1 in non-treated HT-29 cells increased significantly after 24 h of incubation (lanes 1 and 2), while NOB abolished it after 24 h in a concentration-dependent manner (lanes 3 and 4).
Discussion
MMP-7 is known to be associated with the invasiveness [8] [9] [10] and metastasis 37, 38) of cancer cells, and is considered to play several important roles in the development and progression of colorectal, 5) mammary, 39) and prostate 40) cancers, as shown by its expression in benign tumors. Further, MMP-7 gene deficiency has been found to result in suppression of intestinal tumorigenesis.
11) Tissues and cells that express MMP-7 showed a reduced sensitivity for Fas ligand (FasL)/ Fas-induced apoptosis, since MMP-7 is likely to release the non-apoptotic form of soluble FasL by shedding FasL in the cellular membrane. 41, 42) The results of these studies implied that inhibition or suppression of MMP-7 would be beneficial for suppressing metastasis and preventing carcinogenesis, whereas the number of MMP-7 suppressants is limited. For this reason, we searched for compounds disrupting proMMP-7 production, and identified four promising candidates (Fig. 2) .
We reported previously that citrus NOB acted as a dual inhibitor of superoxide and nitric oxide generation in leukocytes, and also identified several in vivo activities, such as suppression of formation of inflammatory mediators, and an anti-tumor promoting effect in mouse skin. 27) More recently, we reported the suppressive effect of NOB on azoxymethane-induced aberrant crypt foci formation in the colon. 36) Of importance, other groups have found that NOB suppressed MMP-9 expression in interleukin-1-treated rabbit synovial fibroblasts, 20) as well as in phorbol ester-stimulated HT-1080 21) and in some brain tumor cell lines that showed a constitutive expression of MMP-9. 22) In addition, inhibition of MMP-9 production by NOB in Fig. 3 . Concentration-Dependent Effects of NOB on proMMP-7
Protein and mRNA Levels.
(A) HT-29 cells were treated with NOB at the indicated concentrations and incubated for 24 h. Media proteins and cell lysates were subjected to Western blotting as described in ''Materials and Methods''. The intracellular proMMP-7 band intensity was corrected with that of -actin as an internal standard. Closed bars, media proMMP-7; open bars, intracellular proMMP-7. *p < 0:05 versus vehicle-treated cells using Student's t-test. Experiments were performed independently 3 times and the data are shown as mean AE SD. (B) Total RNA was isolated from control and NOB (various concentrations)-treated HT-29 cells after incubation for 24 h and subjected to RT-PCR, as described in ''Materials and Methods''. The PCR products of MMP-7 and the internal standard, GAPDH, were electrophoresed and detected on 3% agarose gels stained with SYBR Ò Gold.
a gastric cancer cell line, TMK-1, resulted in the prevention of peritoneal dissemination in SCID mice. 23) But, the effects of NOB on other members of the MMP family remain to be addressed. Herein, we report for the first time that NOB is a distinct suppressant of MMP-7 expression, while abrogation of AP-1 DNA binding activity might, at least in part, be involved in its action mechanisms, supporting the previous notion that NOB is a promising dietary compound for cancer prevention strategies. While activation of AP-1 transcription factor is widely associated with oncogenic processes, the inverse profiles have been shown to emerge, depending upon the composition of AP-1 components (reviewed in 43). For example, junB, an AP-1 component, has been reported to suppress cell proliferation by transcriptional activation of p16. 44) Also, c-Jun knockout mice was embryonic lethal. 45) Therefore, the identification of the AP-1 components in HT-29 cells and their evaluation with respect to benefit for cancer prevention and toxicity ought to be addressed in the near future.
The role of prostaglandins in the expression of proMMP-7 protein is ambiguous, since the effects of COX inhibitors (indomethacin, SC-560, and valeryl salicylate) are conflicting (Fig. 2) . In addition, the molecular mechanism of 4 0 -bromoflavone, an inducer of phase II detoxification enzyme, 34) remains to be addressed. Sulindac sulfone, an oxidative metabolite of sulindac, showed no effect on COX activity, 46) while Thompson et al. reported that it increased cGMP levels by inhibiting cGMP PDE, thereby activating cGMPdependent protein kinase (PKG) for the induction of apoptosis in colon cancer cell lines by the phospho- HT-29 cells were incubated with DMSO (closed squares) or 50 mM of NOB (open circles) for the indicated times. Media (A) and intracellular (B) proMMP-7 proteins were detected using Western blotting. The level of intracellular proMMP-7 was corrected with that of -actin as an internal standard. *p < 0:05; **p < 0:01 versus control group value at each time point using Student's t-test. Data are shown as the mean AE SD from three independent experiments. (C) The level of MMP-7 mRNA in HT-29 cells was measured using RT-PCR, as described in ''Materials and Methods''. The PCR products were electrophoresed and detected on 3% agarose gels stained with SYBR Ò Gold.
rylation of -catenin. 35) -catenin is also an essential factor for maximum expression of the MMP-7 gene. [12] [13] [14] Thus, sulindac sulfone might repress proMMP-7 production by regulating -catenin. Extensive additional study is necessary fully to elucidate the molecular mechanisms of these active compounds.
In conclusion, we discovered four compounds that showed profound inhibitory activity toward proMMP-7 production, suggesting that they might be effective agents to regulate cancer metastasis or carcinogenesis. Further, we found that NOB has a distinct ability highly to suppress MMP-7 expression and production, presumably by blocking AP-1 activity. The molecular mechanisms by which NOB and other compounds downregulate levels of MMP-7 gene expression, as well as their in vivo efficacy, will be further addressed in the near future. HT-29 cells were treated with vehicle or NOB (25 or 100 mM). After the specified times, the nuclear fractions were prepared and AP-1 activity in the extracts was determined, as indicated in ''Materials and Methods''. Lane 1, 0 h; Lane 2, vehicle for 24 h; Lane 3, 25 mM NOB for 24 h; Lane 4, 100 mM NOB for 24 h; Lane 5, vehicle for 24 h + 500-fold excess cold probe. Three independent experiments were performed and a representative image is shown.
